122 related articles for article (PubMed ID: 32210684)
1. Effect of fetal bovine serum on erythropoietin receptor expression and viability of breast cancer cells.
Teo GY; Rasedee A; Al-Haj NA; Beh CY; How CW; Rahman HS; Alitheen NB; Rosli R; Abdullah AH; Ali AS
Saudi J Biol Sci; 2020 Feb; 27(2):653-658. PubMed ID: 32210684
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin alters gene expression and stimulates proliferation of MCF-7 breast cancer cells.
Trost N; Stepisnik T; Berne S; Pucer A; Petan T; Komel R; Debeljak N
Radiol Oncol; 2013; 47(4):382-9. PubMed ID: 24294184
[TBL] [Abstract][Full Text] [Related]
3. Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models.
LaMontagne KR; Butler J; Marshall DJ; Tullai J; Gechtman Z; Hall C; Meshaw A; Farrell FX
Mol Cancer Ther; 2006 Feb; 5(2):347-55. PubMed ID: 16505108
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Human erythropoietin reduces viability of MCF-7 breast cancer cells from 3D culture without caspase activation.
ShujaaEdin HY; Al-Haj NA; Rasedee A; Alitheen NB; Kadir AA; How CW; Rahman HS; Abdullah AH
Saudi J Biol Sci; 2021 Apr; 28(4):2549-2557. PubMed ID: 33935571
[TBL] [Abstract][Full Text] [Related]
5. Correlation between erythropoietin receptor(s) and estrogen and progesterone receptor expression in different breast cancer cell lines.
Trošt N; Hevir N; Rižner TL; Debeljak N
Int J Mol Med; 2013 Mar; 31(3):717-25. PubMed ID: 23314808
[TBL] [Abstract][Full Text] [Related]
6. Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth.
Pharr PN; Hankins D; Hofbauer A; Lodish HF; Longmore GD
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):938-42. PubMed ID: 7679218
[TBL] [Abstract][Full Text] [Related]
7. The Hydroalcoholic Extract of
Nikseresht M; Kamali AM; Rahimi HR; Delaviz H; Toori MA; Kashani IR; Mahmoudi R
Pharmacognosy Res; 2017; 9(1):87-95. PubMed ID: 28250660
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.
Zhang C; Duan X; Xu L; Ye J; Zhao J; Liu Y
Breast Cancer Res Treat; 2012 Dec; 136(3):739-48. PubMed ID: 23117856
[TBL] [Abstract][Full Text] [Related]
9. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
10. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer.
Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S
Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814
[TBL] [Abstract][Full Text] [Related]
12. Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity.
Trost N; Juvan P; Sersa G; Debeljak N
Radiol Oncol; 2012 Sep; 46(3):213-25. PubMed ID: 23077460
[TBL] [Abstract][Full Text] [Related]
13. Lack of expression and function of erythropoietin receptors in the kidney.
Elliott S; Busse L; Swift S; McCaffery I; Rossi J; Kassner P; Begley CG
Nephrol Dial Transplant; 2012 Jul; 27(7):2733-45. PubMed ID: 22167585
[TBL] [Abstract][Full Text] [Related]
14. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development.
Sawada K; Krantz SB; Dessypris EN; Koury ST; Sawyer ST
J Clin Invest; 1989 May; 83(5):1701-9. PubMed ID: 2651478
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin in combination with chemotherapy increases breast cancer metastasis in preclinical mouse models.
Hedley BD; Chu JE; Ormond DG; Beausoleil MS; Boasie A; Allan AL; Xenocostas A
Clin Cancer Res; 2011 Oct; 17(19):6151-62. PubMed ID: 21856770
[TBL] [Abstract][Full Text] [Related]
16. Effect of erythropoietin, 5-fluorouracil and SN-38 on the growth of DLD-1 cells.
Tankiewicz-Kwedlo A; Pawlak D; Domaniewski T; Buczko W
Pharmacol Rep; 2010; 62(5):926-37. PubMed ID: 21098876
[TBL] [Abstract][Full Text] [Related]
17. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR.
McArthur GA; Longmore GD; Klingler K; Johnson GR
Exp Hematol; 1995 Jul; 23(7):645-54. PubMed ID: 7601257
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway.
Yoon D; Watowich SS
Exp Hematol; 2003 Dec; 31(12):1310-6. PubMed ID: 14662339
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the erythropoietin receptor in RAMA 37 breast cancer cells alters cell growth and sensitivity to tamoxifen.
Ilkovičová L; Trošt N; Szentpéteriová E; Solár P; Komel R; Debeljak N
Int J Oncol; 2017 Aug; 51(2):737-746. PubMed ID: 28714517
[TBL] [Abstract][Full Text] [Related]
20. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
